Further work is needed to fully understand the mechanisms of action of CKI on cell migration and invasion, the signaling pathways involved, the synergistic effects of combined therapeutic agents, and the translational potential by extending these analyses to metastatic cancer cells in vivo. This evidence concerns the gene CHKA and metastatic malignant neoplasm.